Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 7/20 | 0.43 |
| ▸ | CES2 | O00748 | 6/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8582939 | 0.94 | CES1 (0.47) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL9713106 | 0.91 | CES2 (0.46) | CES1CES2ALDH1A1TSHRAKR1B1 | |
| Ammonia Solution, Strong SCHEMBL28852850 | 0.90 | CES1 (0.45) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL10496754 | 0.88 | CES2 (0.48) | CES1CES2ALDH1A1TSHRTHRB | |
| SCHEMBL3335255 | 0.88 | CES2 (0.48) | CES1CES2ALDH1A1TSHRTHRB | |
| SCHEMBL7698922 | 0.88 | CES2 (0.48) | CES1CES2ALDH1A1TSHRAKR1B1 | |
| SCHEMBL4075418 | 0.87 | CES1 (0.47) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL5961192 | 0.87 | CES1 (0.47) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL26822 | 0.87 | — | — | |
| SCHEMBL1678094 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016037223-A1 | DIRHODIUM COMPOUNDS AND METHODS OF USE | GHANEM ASHRAF (AU) | 2016-03-17 | — | — | WO | claimed |
| CN-118302485-A | Resin composition | 日产化学株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-117099046-A | Photosensitive resin composition for forming insulating film | 日产化学株式会社 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023176259-A1 | PHOTOSENSITIVE RESIN COMPOSITION FOR FORMING INSULATING FILM | 日産化学株式会社 | 2023-09-21 | — | — | WO | disclosed |
| WO-2023106101-A1 | RESIN COMPOSITION | 日産化学株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-2023106108-A1 | PHOTOSENSITIVE RESIN COMPOSITION | 日産化学株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-11643544-B2 | Resin composition, and prepreg, metal-clad laminate, and printed circuit board prepared using the same | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2023-05-09 | — | — | US | disclosed |
| CN-108349919-B | Polyfunctional epoxy compound and curable composition containing the same | 日产化学工业株式会社 | 2022-06-03 | — | — | CN | disclosed |
| CN-114254630-A | Translation method, translation device, electronic equipment and readable storage medium | 北京捷通华声科技股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-114037501-A | Structural recommendation algorithm, device and equipment based on heterogeneous feedback | 深圳大学 | 2022-02-11 | — | — | CN | disclosed |
| US-20030130523-A1 | Substituted chiral allosteric hemoglobin modifiers | ABRAHAM DONALD J (US) | 2003-07-10 | — | — | US | disclosed |
| US-6486342-B1 | Substituted chiral allosteric hemoglobin modifiers | VIRGINIA COMMONWEALTH UNIVERSITY | 2002-11-26 | — | — | US | disclosed |
| US-5194621-A | Lubricant additives for improved wear and oxidation resistance | R. T. VANDERBILT COMPANY, INC. (US) | 1993-03-16 | — | — | US | disclosed |
| US-5187159-A | Hypotensive agents, psychological disorders | MERCK & CO., INC. (US) | 1993-02-16 | — | — | US | disclosed |
| US-4970331-A | Vinyl ethers and fluorine-containing copolymers prepared therefrom | DAIKIN INDUSTRIES, LTD. (JP) | 1990-11-13 | — | — | US | disclosed |
| US-4904814-A | CATALYTIC TRANSESTERIFICATION OF METHYL OR ETHYL ESTERS WITH TERTIARY ALCOHOL | CIBA-GEIGY CORPORATION (US) | 1990-02-27 | — | — | US | disclosed |
| US-4804654-A | INSECTICIDES, MITICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-02-14 | — | — | US | disclosed |
| EP-0278914-A2 | Process for the preparation of tert.-alkyl esters of succinic acid | CIBA-GEIGY AG (CH) | 1988-08-17 | — | — | EP | disclosed |
| CN-87103208-A | PHOSPHORAMIDO COMPOUNDS | — | 1988-08-17 | — | — | CN | disclosed |
| US-3933889-A | 4,5-Cis-didehydro-PGF1.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130523-A1 | Substituted chiral allosteric hemoglobin modifiers | HBZ, HBB, HBG2 | CES1 3350/4885CES2 4335/4885ALDH1A1 4454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.